Biohaven (BHVN) Net Income towards Common Stockholders (2021 - 2026)

Biohaven (BHVN) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$130.5 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 41.12% year-over-year to -$130.5 million; the trailing twelve-month figure through Mar 2026 stood at -$647.7 million (up 27.11% YoY), and the FY2025 full-year result was -$738.8 million, up 12.71% from the prior year.
• Net Income towards Common Stockholders advanced to -$130.5 million in Q1 2026, from -$145.6 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$68.9 million in Q3 2022 to a low of -$319.8 million in Q2 2024.
• A 5-year average of -$158.5 million and a median of -$160.3 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders plunged 287.59% in 2022 and soared 55.56% in 2023, its largest moves.
• Tracing BHVN's Net Income towards Common Stockholders over 5 years: stood at -$201.1 million in 2022, then gained by 28.02% to -$144.8 million in 2023, then fell by 29.07% to -$186.8 million in 2024, then advanced by 22.1% to -$145.6 million in 2025, then advanced by 10.32% to -$130.5 million in 2026.
• Business Quant data shows BHVN's Net Income towards Common Stockholders at -$130.5 million in Q1 2026, -$145.6 million in Q4 2025, and -$173.4 million in Q3 2025.